Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1972 1
1980 3
1981 1
1987 3
1988 1
1989 2
1991 1
1992 3
1993 1
1994 1
1996 2
1998 1
1999 2
2001 1
2002 4
2003 2
2004 1
2005 2
2006 7
2007 4
2008 8
2009 1
2010 3
2011 7
2012 8
2013 11
2014 8
2015 6
2016 6
2017 6
2018 9
2019 12
2020 18
2021 19
2022 25
2023 19
2024 12
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation.
Wu L, Seung E, Xu L, Rao E, Lord DM, Wei RR, Cortez-Retamozo V, Ospina B, Posternak V, Ulinski G, Piepenhagen P, Francesconi E, El-Murr N, Beil C, Kirby P, Li A, Fretland J, Vicente R, Deng G, Dabdoubi T, Cameron B, Bertrand T, Ferrari P, Pouzieux S, Lemoine C, Prades C, Park A, Qiu H, Song Z, Zhang B, Sun F, Chiron M, Rao S, Radošević K, Yang ZY, Nabel GJ. Wu L, et al. Among authors: lemoine c. Nat Cancer. 2020 Jan;1(1):86-98. doi: 10.1038/s43018-019-0004-z. Epub 2019 Nov 18. Nat Cancer. 2020. PMID: 35121834
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Diamond B, Baughn L, Poorebrahim M, Poos AM, Lee H, Kaddoura M, Wiedmeier-Nutor JE, Durante M, Otteson G, Jevremovic D, Tang H, Fröhling S, Baertsch MA, Papadimitriou M, Ziccheddu B, Jelinek T, Lemoine C, Rak A, Green DJ, Landgren O, Neri P, Bergsagel L, Braggio E, Kumar S, Raab MS, Fonseca R, Bahlis N, Weinhold N, Maura F. Diamond B, et al. Among authors: lemoine c. Blood. 2025 Sep 25;146(13):1575-1585. doi: 10.1182/blood.2024028107. Blood. 2025. PMID: 40493883 Free PMC article.
Bortezomib.
Tariman JD, Lemoine C. Tariman JD, et al. Among authors: lemoine c. Clin J Oncol Nurs. 2003 Nov-Dec;7(6):687-9. doi: 10.1188/03.CJON.687-689. Clin J Oncol Nurs. 2003. PMID: 14705489 No abstract available.
TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasia.
Starrett JH, Lemoine C, Guillo M, Fayad C, Kaci N, Neal M, Pettitt EA, Pache M, Ye Q, Chouinard M, Allen EL, Baujat G, Hudkins RL, Bober MB, Harris T, Swanson RV, Legeai-Mallet L. Starrett JH, et al. Among authors: lemoine c. JCI Insight. 2025 Apr 3;10(9):e189307. doi: 10.1172/jci.insight.189307. eCollection 2025 May 8. JCI Insight. 2025. PMID: 40178985 Free PMC article.
Overview of pediatric kidney transplantation.
Lemoine CP, Pozo ME, Superina RA. Lemoine CP, et al. Semin Pediatr Surg. 2022 Jun;31(3):151194. doi: 10.1016/j.sempedsurg.2022.151194. Epub 2022 May 29. Semin Pediatr Surg. 2022. PMID: 35725053
Precision medicine for nurses: 101.
Lemoine C. Lemoine C. Semin Oncol Nurs. 2014 May;30(2):84-99. doi: 10.1016/j.soncn.2014.03.002. Semin Oncol Nurs. 2014. PMID: 24794082 Review.
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis.
Rossignol P, Zannad F, Massy Z, Azizi M, Chorfa F, Coadic J, Ferreira JP, Saraiva F, Mottier D, Guillemin F, Ngueyon Sime W, Bouali S, Rossignol B, Nortier J, Simon I, Robino C, Davin M, Bataille PM, Chantrel F, Castin N, Esnault V, Kazes I, Hannedouche T, Kamar N, Achard JM, Fenerol C, Achard-Hottelart C, Dimitrov Y, Girerd N, Maucourt-Boulch D, Frimat L; ALCHEMIST study group. Rossignol P, et al. Lancet. 2025 Aug 16;406(10504):705-718. doi: 10.1016/S0140-6736(25)01194-8. Lancet. 2025. PMID: 40818851 Clinical Trial.
Technological Approaches for Improving Vaccination Compliance and Coverage.
Lemoine C, Thakur A, Krajišnik D, Guyon R, Longet S, Razim A, Górska S, Pantelić I, Ilić T, Nikolić I, Lavelle EC, Gamian A, Savić S, Milicic A. Lemoine C, et al. Vaccines (Basel). 2020 Jun 16;8(2):304. doi: 10.3390/vaccines8020304. Vaccines (Basel). 2020. PMID: 32560088 Free PMC article. Review.
208 results